MHMaria Vaitsa Loch Haskel

Maria Vaitsa Loch Haskel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maria Vaitsa Loch Haskel has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Neuroprotective effects of curcumin and apocynin on spatial memory performance in an animal model of acute neuroinflammation / Efeitos neuroprotetores de curcumina e apocinina sobre o desempenho em memória espacial em modelo animal de neuroinflamação aguda

    by Paola Fernanda de Souza, Maria Vaitsa L. Haskel, Elizama de Gregório, Daniele de Paula, Emilaynne R. Bensberg, Carlos Ricardo M. Malfatti, Juliana Sartori Bonini, Weber Cláudio da Silva

    Neuroinflammation is closely related to the etiology of several neurological/neurodegenerative diseases. These disorders cause cognitive impairment and sensitization of the immune system to internal and/or external stimuli. This work aims to evaluate the neuroprotective effects of the phytochemical compounds curcumin and apocynin on the spatial memory of rats in a model of acute neuroinflammation. For this, the study was divided into two phases. First, the dose of lipopolysaccharide (LPS) able to cause neuroinflammation and consequently mnemonic damage to the animals was tested. In the second phase, the neuroprotective effect of curcumin and apocynin was assessed. At two days after the surgery, the treatment with curcumin 50 mg/kg dissolved in vegetable oil was administered by gavage to saline + curcumin and LPS + curcumin groups. On the same day, animals from groups saline + apocynin and LPS + apocynin received by gavage apocynin 50 mg/kg suspended in distilled water. Rats of saline + vehicle and LPS + vehicle groups received vegetable oil or distilled water. The gavage treatment was given for 30 days for all groups. The spatial memory evaluation was assessed by Morris Water Maze (MWM) task, performed 30 days after the surgery in the first phase of the study and 1 day after the last gavage treatment in the second phase, both for 5 consecutive days. The MWM test trial was conducted 24 hours after the last training session. We found that the intra-hippocampal infusion of LPS, performed 30 days before training in the MWW task, impaired the retention of spatial memory acquired in this task. It also caused histopathological alterations in the infusion region, which are compatible with both acute and chronic neuroinflammation. Oral administration of apocynin, but not curcumin, reversed the mnemonic deficit and mitigated the histopathological alterations caused by the intra-hippocampal infusion of LPS.

  • Open Access

    Influence of Alzheimer's disease on the relationship between nutritional status and risk of fall

    by Maria Vaitsa Loch Haskel, Sara Carolina Scremin Souza, Danilo Fernandes da Silva, Weber Cláudio Francisco Nunes da Silva, Juliana Sartori Bonini

    Although malnutrition and risk of falls in the elderly have increased in recent years, uncertainties exist as to whether these conditions are associated after controlling for sociodemographic variables, body composition, metabolic condition, and Alzheimer's disease (AD). This study aimed to analyze the association between nutritional status and risk of fall in the elderly population. Participants were matched by gender and age, after they had been grouped on the basis of diagnosis of AD. The risk of falls, nutritional status, and mental status were assessed using the Downton Fall Risk Score (FRS), Mini Nutritional Assessment (MNA), and Mini Mental State Evaluation (MMSE), respectively. Logistic regression models adjusted for the main confounders were used in the analyses. Among the 68 elderly individuals studied, participants who were malnourished or at risk of malnutrition were more likely to fall (odds ratio = 8.29; 95% confidence interval = 1.49-46.04) than those with normal nutritional status, regardless of gender, age, education, body composition, and metabolic condition. This association did not remain significant after adjustment for AD, a potential confounder in this association. Malnutrition or its risk was independently associated with high risk of fall; thus, malnutrition should be considered in the prevention of falls among the elderly population.

  • Open Access

    Polypharmacy in Alzheimer's disease patients in Brazil: Guidance for pharmaceutical assistance

    by Felipe Nathanael Coelho Vaz, Luana Bortoluzzi Trombim, Guilherme Barroso L. de Freitas, Maria Vaitsa Loch Haskel, Giovana dos Santos, Jéssica Wouk, Dayanna Hartmann Cambruzzi Mendes, Barbara Luisa Fermino, Flávia Ivanski, Juliana Sartori Bonini

    Background: Elderly patients frequently have concomitant diseases, triggering the necessity of utilizing several different medications, which can cause adverse events associated with therapy, called polypharmacy. This study aimed to evaluate the main concomitant diseases with Alzheimer's disease (AD) and discuss possible interactions between drugs utilized to treat dementia and its comorbidities, and indicate safe medicines for patients with AD. Methods: 41 individuals with AD who withdraw medicines for dementia from the Brazilian public health system (SUS) participated in this study. Data collection was performed using three questionnaires: 1) Clinical Dementia Rating, to verify disease stage; 2) Mini–mental state examination, to measure cognitive impairment; and 3) Sociodemographic analysis, to evaluate concomitant diseases, utilized drugs, drug-drug interactions, among other demographic variables. Statistical analyses were performed using SPSS and data was presented as relative frequency. Results: The results of this study showed that the most frequent concomitant diseases with AD are: systemic arterial hypertension, depression, diabetes mellitus, and hypercholesterolemia. Polypharmacy was observed in 95.12% of patients. The pharmacologic classes that presented interactions with AD medications were anxiolytics, antidepressants, antipsychotics, antihypertensives, and antidiabetics. Conclusion: In the present study, polypharmacy in patients with AD and other concomitant diseases has been characterized. The average number of drugs that these patients ingested was seven per day, and this leads to drug interactions, which are potentially damaging to the body. Consequently, we have tried to reduce these interactions, by suggesting drugs that are safer, for example furosemide instead of amlodipine to treat hypertension.